INTUITIVE SURGICAL INC (ISRG) Earnings History

5 quarters held1/3 transcripts analyzed1/25 figures attested
Connect your agent
PeriodRevenueYoYNet incomeEPS (dil.)Filed
Q2 2026$2.9B+18.5%$823.2M$2.29Jul 16, 2026
LATESTEarnings filing (8-K)10-QFiled Jul 16, 2026, 4:05 PM ET
Earnings call · Jul 16, 2026
Q2 FY26YoY6M FY26
Revenue$2.9B1+18.5%$5.7B
Net income$823.2M+23.9%–
Op income$971.9M+30.7%$1.8B
EPS (dil.)$2.29+26.5%–
EPS (basic)$2.31+25.5%–
Gross margin67.8%+1.5pp
Op margin33.6%+3.1pp
Net margin28.5%+1.2pp
  1. [1] “Total revenue 2,892.3” view source

Guidance & outlook

Management guidance

Q2 2026

fy_current

other
14—16

Special items & operational metrics

Operational metrics

Q2 2026
Da Vinci 5 Systems Placed
246
+36.7% YoY
Prior year: 180
units
Da Vinci Installed Base
11.7K
+11.7% YoY
Prior year: 10.5K
systems
Da Vinci Procedures Growth Pct
15
percent
Da Vinci Systems Placed
468
+18.5% YoY
Prior year: 395
units
Ion Installed Base
1.1K
+21.1% YoY
Prior year: 905
systems
Ion Procedures Growth Pct
36
percent
Ion Systems Placed
55
+1.9% YoY
Prior year: 54
units
Worldwide Procedures Growth Pct
16
percent
Q1 2026$2.8B–$826.0M$2.28Apr 21, 2026
Earnings filing (8-K)10-QFiled Apr 21, 2026, 4:09 PM ET
Earnings call · Apr 21, 2026
Q1 FY26YoY
Revenue$2.8B–
Net income$826.0M–
Op income$855.3M–
EPS (dil.)$2.28+18.8%
EPS (basic)$2.31+18.5%
Gross margin66.1%+1.4pp
Op margin30.9%+5.2pp
Net margin29.6%-1.4pp
Q4 2025$2.9B+18.8%$794.8M$2.21Jan 22, 2026
Earnings filing (8-K)10-KFiled Jan 22, 2026, 4:05 PM ET
Earnings call · Jan 22, 2026transcriptprepared remarksQ&A
Q4 FY25YoYFY25
Revenue$2.9B+18.8%$10.1B
Net income$794.8M+15.9%$2.9B
Op income$864.3M+17.6%$2.9B
EPS (dil.)$2.21+17.6%$7.87
EPS (basic)$2.24+16.7%$8.00
Gross margin66.4%-1.6pp
Op margin30.1%-0.3pp
Net margin27.7%-0.7pp
Q3 2025$2.5B+23.0%$704.4M$1.95Oct 21, 2025
Earnings filing (8-K)10-QFiled Oct 21, 2025, 4:03 PM ET
Q3 FY25YoY9M FY25
Revenue$2.5B+23.0%–
Net income$704.4M+24.6%$2.1B
Op income$759.7M+31.6%$2.1B
EPS (dil.)$1.95+25.0%$5.67
EPS (basic)$1.98+24.5%$5.77
Gross margin66.4%-1.0pp
Op margin30.3%+2.0pp
Net margin28.1%+0.4pp
Q2 2025$2.4B+21.4%$658.4M$1.81Jul 22, 2025
Earnings filing (8-K)10-QFiled Jul 22, 2025, 4:03 PM ET
Q2 FY25YoY6M FY25
Revenue$2.4B+21.4%$4.7B
Net income$658.4M+25.0%$1.4B
Op income$743.4M+31.0%$1.3B
EPS (dil.)$1.81+24.0%$3.72
EPS (basic)$1.84+24.3%$3.79
Gross margin66.3%-2.0pp
Op margin30.5%+2.3pp
Net margin27.0%+0.8pp

IR event calendar

This company's IR event calendar has not been harvested yet — an empty result here does NOT mean the company has no IR events.

Filing coverage

57 filings indexed · 48,249 XBRL facts
FilingDatePeriodSectionsTables
8-K2026-07-27–30
10-Q2026-07-21–3659
8-K2026-07-16Q2 202680
8-K2026-05-28–10
8-K2026-05-04–20
10-Q2026-04-22–3554
8-K2026-04-21Q1 202670
DEF 14A2026-03-13–240
8-K2026-03-02–30
10-K2026-02-03–3221

Showing the latest 10 of 57 — the full set is in the API.

Related Research

Analysis

Boston Scientific Hit a ROIC Inflection — Then Bet $14.5B on Penumbra

Analysis

What ISRG's 21.6% ROIC Reveals: Surgical Robotics Moat Under the Microscope